Colorectal cancer: A rational follow-up program adapted to patient's individual risk of recurrence;Patientenorientierte, risikoadaptierte Tumornachsorge bei Patienten mit kolorektalem Karzinom

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 11, 1997, Pages 1019-1027

  Schorr, M ^a   Siebeck, M ^a   Zoller, W G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

colorectal cancer; efficacy; follow up

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; COST; FOLLOW UP; HUMAN; REVIEW;

AFTERCARE; CARCINOMA; COLORECTAL NEOPLASMS; EFFICIENCY, ORGANIZATIONAL; HUMANS; PATIENT-CENTERED CARE; RISK FACTORS;

EID: 0030670487     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Mezger J, Glasmacher A, Sauerbruch T. Nachsorge bei Patienten mit kolorektalen Karzinomen. Dtsch med Wochenschr 1995; 120: 1549-54
2. Bruinvels DJ, Stiggelbout AM, Kievit J et al. Follow-up of patients with colorectal cancer. Ann Surg 1994; 219 (2): 174-82
3. Mäkela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Arch Surg 1995; 130: 1062-7
4. Schölmerich J. Sinn und Unsinn der Nachsorge bei kolorektalem Karzinom. Med Klin 1996; 91: 420-7
5. Safi F, Link KH, Beger HG. Is follow-up of colorectal cancer patients worthwhile? Dis-Colon-Rectum 1993; 36 (7): 636-44
6. Böhin B, Oßwald J, Hucke HP, Stock W. Individuelle risikoadaptierte Nachsorge beim kolorektalen Karzinom? Langenbccks Arch Chir 1991; 376: 314-22
7. Kelly CJ, Daly JM. Colorectal cancer: Principles of postoperative follow-up. Cancer Suppl 1992; 70 (5): 1397-1408
8. Sugarbaker PH, Gianola FJ, Dwyer A, Neumann NR. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987; 102: 79-87
9. McCall JL, Blank RB, Rich CA et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37: 875-81
10. Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994; 37: 272-7
11. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994; 60: 528-32
12. Moertel CG, Fleming TR, MacDonald JS et al. An evaluation of the carcino-embryonic antigen (CEA) test for monitoring patients with resected colon cancer. J Amer med Ass 1993; 270: 943-5
13. Kievit J, van de Velde CJH. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up. Cancer 1990; 65: 2580-87
14. Hida J, Yasutomi M, Sindoh K et al. Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques. Dis Colon Rectum 1996; 39: 74-9
15. Stapel A, Franke U, Putzki H. Die Bedeutung von CEA und CA 19-9 für die Nachsorge kurativ resezierter kolorektaler Karzinome. Zentbl Chir 1992; 117: 77-80
16. Reiter W, Stieber P, Reuter C et al. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. Anticancer Res 1997; 17: 2935-8
17. Leen E, Angerson WJ. Wotherspoon H et al. Detection of colorectal liver metastases: Comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 1995; 195 (1): 113-6
18. Schölmerich J, Volk BA, Neuner C, Fröhlich J, Gerok W. Aussagefähigkeit der Sonographie bei Lebermetastasen. Dtsch med Wochenschr 1984; 109: 326-9
19. Wernecke K, Rummeny E, Bongartz G et al. Detection of hepatic masses in patients with carcinoma. Comparative sensitivities of songography, CT and MR imaging. Am J Roentgenol 1991; 157: 731
20. Stautner-Brückmann C, Schneider W, Grosser U et al. Is ultrasound superior to carcinoembryonic antigen (CEA) measurement in recurrent tumor screening of patients with colorectal cancer? Bildgebung 1990; 57: 17-20
21. Beynon JM, Mortensen NJ. Foy DMA et al. The detection and evaluation of locally recurrent rectal cancer with rectal endosonography. Dis Col Rectum 1989; 32: 509-17
22. Meyenberger C, Huch-Boni RA, Bertschinger P et al. Endoscopic ultrasound and endorectal magnetic resonance imaging: A prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995; 27: 469-79
23. Meyenberger C, Wildi S, Kulling D et al. Tumor staging and follow-up care in rectosigmoid carcinoma: Colonoscopic endosonography compared to CT, MRI and endorectal MRI. Schweiz Rundsch Med Prax 1996; 85: 622-31
24. Herzog U, von Flue M, Tan KG et al. Strength and weaknesses of endorectal ultrasonography. Schweiz Med Wochenschr 1993; 123: 1111-4
25. Hünerbein M, Below C, Schlag PM. Three-dimensional endorectal ultrasonography for staging of obstructing rectal cancer. Dis Col Rectum 1996; 39: 636-42
26. De Gara CJ, Harpur G, Basrur V, North W, Knight P. The value of endorectal ultrasonography in the follow-up of intracavitary radiation treated early rectal cancer. Surg Oncol 1995; 4: 15-9
27. Williamson PR, Hellinger MD, Larach SW, Ferrara A. Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis Col Rectum 1996; 39: 45-9
28. Hermanek jr. P, Wiebelt H, Riedl St, Staimmer D, Hermanek P. Langzeitergebnisse der chirurgischen Therapie des Coloncarcinoms. Chirurg 1994; 65: 287-97
29. Lautenbach E, Forde KA, Neugut AI. Benefits of colonoscopic surveillance after curative resection of colorectal cancer. Ann Surg 1994; 220 (2): 206-11
30. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5
31. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326 (10): 653-7
32. Eckardt VF, Stamm H, Kanzler G, Bernhard G. Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance program. Endoscopy 1994; 26 (6): 523-7
33. Feuerstein IM, Jicha DL, Pass HI et al. Pulmonary metastases: MR imaging with surgical correlation - a prospective study. Radiology 1992; 182 (1): 123-9
34. Chalmers N, Best JJ. The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging. Clin Radiol 1991; 44 (6): 410-2
35. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. New England J Med 1993; 328 (19): 1365-71
36. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-18
37. Leen E, Angerson WG, Cooke TG, McArdle CS. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival. Ann Surg 1996; 223: 199-203
38. Diez M, Camunas J, Enriquez JM et al. A comparative study on the prognostic value of the nuclear expression of protein p53 vis-a-vis histopathology in colorectal cancer. An Med Interna 1996; 13: 222-6
39. Kressner U, Lindmark G, Gerdin B, Pahlman L, Glimelius B. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Anticancer Res 1996; 16: 951-7
40. Collier BD, Abdel Nabi H, Doerr RJ et al. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: Comparison with CT. Radiology 1992; 185: 179-86
41. Blend MJ, Abdel Nabi H. New methods for the staging of colorectal cancer using noninvasive techniques. Sem Surg Oncol 1996; 12: 253-63
42. Pounds TR, Valk PE, Haseman MK et al. Whole body PET-FDG imaging in diagnosis of recurrent colorectal cancer. J Nucl Med 1995; 36 (P): 57
43. Eckardt VF, Bernhard G. Nachsorge beim kolorektalen Karzinom. Deutsches Ärzteblatt 1997; 94 (8): 377-83
44. Winawer SJ, St. John DJ, Bond JH et al. Prevention of colorectal cancer: Guidelines based on new data. Bulletin of the World Health Organization 1995; 73 (1): 7-10
45. Zoller WG, Gross M. Tumornachsorge am Beispiel des kolorektalen Karzinoms: Wann in der Klinik -wann in der Praxis ? Der Bay Int 1996; 16 (suppl 2): 17-24
46. Ohlsson B, Breland U, Ekberg H et al. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-26